Cutaneous graft-versus-host disease: rationales and treatment options.
about
Organ-specific management and supportive care in chronic graft-versus-host disease.Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update.Cutaneous manifestations of graft-versus-host disease: role of the dermatologist.Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions.Role of Toll-like receptor 4 signaling in cutaneous chronic graft-versus-host disease.
P2860
Cutaneous graft-versus-host disease: rationales and treatment options.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cutaneous graft-versus-host disease: rationales and treatment options.
@en
Cutaneous graft-versus-host disease: rationales and treatment options.
@nl
type
label
Cutaneous graft-versus-host disease: rationales and treatment options.
@en
Cutaneous graft-versus-host disease: rationales and treatment options.
@nl
prefLabel
Cutaneous graft-versus-host disease: rationales and treatment options.
@en
Cutaneous graft-versus-host disease: rationales and treatment options.
@nl
P2860
P1433
P1476
Cutaneous graft-versus-host disease: rationales and treatment options.
@en
P2093
Rahul Chavan
Rokea el-Azhary
P2860
P304
P356
10.1111/J.1529-8019.2011.01397.X
P577
2011-03-01T00:00:00Z